Received Jun 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | — | — |
My daughter six months ago vaccinated with bexsero (first dose)/She is 5 years old.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of inappropriate age at vaccine administration in a 5-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: My daughter six months ago vaccinated with bexsero (first dose)/She is 5 years old.). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 04-JUN-2025 This case was reported by interactive digital media The reporter reported that daughter six months ago vaccinated with his/her Bexsero (first dose) and now they were going for the second dose. The reporter reported did she need a third dose. 5 year old patient received Bexsero which led to, Inappropriate age at vaccine administration.